Department of Hepatopancreatobiliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Department of Hepatopancreatobiliary Surgery, Regional Academic Cancer Center Utrecht, St. Antonius Hospital Nieuwegein and University Medical Center Utrecht, Utrecht, The Netherlands.
Ann Surg Oncol. 2020 Aug;27(8):2949-2958. doi: 10.1245/s10434-020-08304-0. Epub 2020 Mar 10.
Intraoperative para-aortic lymph node (PALN) sampling during surgical exploration in patients with suspected pancreatic head cancer remains controversial.
The aim of this study was to assess the value of routine PALN sampling and the consequences of different treatment strategies on overall patient survival.
A retrospective, multicenter cohort study was performed in patients who underwent surgical exploration for suspected pancreatic head cancer. In cohort A, the treatment strategy was to avoid pancreatoduodenectomy and to perform a double bypass procedure when PALN metastases were found during exploration. In cohort B, routinely harvested PALNs were not examined intraoperatively and pancreatoduodenectomy was performed regardless. PALNs were examined with the final resection specimen. Clinicopathological data, survival data and complication data were compared between study groups.
Median overall survival for patients with PALN metastases who underwent a double bypass procedure was 7.0 months (95% confidence interval [CI] 5.5-8.5), versus 11 months (95% CI 8.8-13) in the pancreatoduodenectomy group (p = 0.049). Patients with PALN metastases who underwent pancreatoduodenectomy had significantly increased postoperative morbidity compared with patients who underwent a double bypass procedure (p < 0.001). In multivariable analysis, severe comorbidity (ASA grade 2 or higher) was an independent predictor for decreased survival in patients with PALN involvement (hazard ratio 3.607, 95% CI 1.678-7.751; p = 0.001).
In patients with PALN metastases, pancreatoduodenectomy was associated with significant survival benefit compared with a double bypass procedure, but with increased risk of complications. It is important to weigh the advantages of resection versus bypass against factors such as comorbidities and clinical performance when positive intraoperative PALNs are found.
在疑似胰头癌患者的手术探查中,术中腹主动脉旁淋巴结(PALN)取样仍然存在争议。
本研究旨在评估常规 PALN 取样的价值,以及不同治疗策略对总体患者生存的影响。
对接受疑似胰头癌手术探查的患者进行回顾性、多中心队列研究。在队列 A 中,当探查时发现 PALN 转移时,治疗策略是避免胰十二指肠切除术并进行双重旁路手术。在队列 B 中,常规采集的 PALN 未在术中进行检查,无论是否存在转移均进行胰十二指肠切除术。PALN 与最终切除标本一起检查。比较研究组之间的临床病理数据、生存数据和并发症数据。
接受双重旁路手术的 PALN 转移患者的中位总生存期为 7.0 个月(95%置信区间 [CI] 5.5-8.5),而接受胰十二指肠切除术的患者为 11 个月(95% CI 8.8-13)(p=0.049)。接受胰十二指肠切除术的 PALN 转移患者术后发病率明显高于接受双重旁路手术的患者(p<0.001)。多变量分析显示,严重合并症(ASA 分级 2 级或更高)是 PALN 受累患者生存时间缩短的独立预测因素(风险比 3.607,95%CI 1.678-7.751;p=0.001)。
在 PALN 转移患者中,与双重旁路手术相比,胰十二指肠切除术与显著的生存获益相关,但并发症风险增加。当发现术中 PALN 阳性时,需要权衡切除与旁路的优势,与合并症和临床表现等因素进行权衡。